Efficacy and safety of rituximab biosimilar in refractory lupus

Duane Peters from the Lupus Foundation of America interviews Dr Pintip Ngamjanyaporn and Dr Nantakarn Pongtarakulpanit from Mahidol University in Bangkok, Thailand, about their study on the short term efficacy and safety of rituximab biosimilar in refractory lupus.

Access the paper here: https://lupus.bmj.com/content/7/1/e000442